Welcome to LookChem.com Sign In|Join Free
  • or
N-Isopropylhydroxylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

5080-22-8

Post Buying Request

5080-22-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5080-22-8 Usage

Uses

N-Isopropylhydroxylamine is used in preparation method of Methylstyrene Butadiene rubber.

Check Digit Verification of cas no

The CAS Registry Mumber 5080-22-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,8 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5080-22:
(6*5)+(5*0)+(4*8)+(3*0)+(2*2)+(1*2)=68
68 % 10 = 8
So 5080-22-8 is a valid CAS Registry Number.
InChI:InChI=1/2C3H9NO.H2O4S/c2*1-3(2)4-5;1-5(2,3)4/h2*3-5H,1-2H3;(H2,1,2,3,4)

5080-22-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Isopropylhydroxylamine

1.2 Other means of identification

Product number -
Other names IPHA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Corrosion inhibitors and anti-scaling agents,Processing aids, specific to petroleum production
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5080-22-8 SDS

5080-22-8Synthetic route

2-Isopropyl-3-methyl-5-oxo-2,5-dihydro-isoxazole-4-carboxylic acid ethyl ester
113768-49-3

2-Isopropyl-3-methyl-5-oxo-2,5-dihydro-isoxazole-4-carboxylic acid ethyl ester

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

Conditions
ConditionsYield
With hydrogenchloride; acetic acid In water96%
2-nitropropane
79-46-9

2-nitropropane

A

isopropylamine
75-31-0

isopropylamine

B

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

Conditions
ConditionsYield
With hydrogen In para-xylene; isopropyl alcohol at 25℃; under 760.051 Torr; for 4h;A 9%
B 88%
2-nitropropane
79-46-9

2-nitropropane

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

Conditions
ConditionsYield
With ammonia borane; gold on titanium oxide In ethanol at 20℃; for 0.666667h; Inert atmosphere;85%
elektrochemische Reduktion;
With ammonia; sodium at -33.5℃;
hydrogenchloride
7647-01-0

hydrogenchloride

3-nitro-benzaldehyde-(N-isopropyl oxime )

3-nitro-benzaldehyde-(N-isopropyl oxime )

A

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

B

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

m-nitro-N-isopropyl-isobenzaldoxime

m-nitro-N-isopropyl-isobenzaldoxime

A

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

B

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

Conditions
ConditionsYield
With hydrogenchloride
2-nitropropane
79-46-9

2-nitropropane

ammonia
7664-41-7

ammonia

sodium

sodium

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

hydrogenchloride
7647-01-0

hydrogenchloride

acetone oxime
127-06-0

acetone oxime

platinum black

platinum black

A

N,N-diisopropylhydroxylamine
5765-61-7

N,N-diisopropylhydroxylamine

B

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

C

N-isopropyl-hydroxylammonium chloride

N-isopropyl-hydroxylammonium chloride

D

N.N-diisopropyl-hydroxylammonium chloride

N.N-diisopropyl-hydroxylammonium chloride

Conditions
ConditionsYield
Hydrogenation;
oxalic acid
144-62-7

oxalic acid

acetone oxime
127-06-0

acetone oxime

platinum black

platinum black

A

N,N-diisopropylhydroxylamine
5765-61-7

N,N-diisopropylhydroxylamine

B

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

C

N-isopropyl-hydroxylammonium oxalate

N-isopropyl-hydroxylammonium oxalate

D

N.N-diisopropyl-hydroxylammonium oxalate

N.N-diisopropyl-hydroxylammonium oxalate

Conditions
ConditionsYield
Hydrogenation;
acetone oxime
127-06-0

acetone oxime

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

Conditions
ConditionsYield
Inert atmosphere;
Stage #1: acetone oxime With sodium cyanoborohydride In methanol at 20℃; for 4h;
Stage #2: With hydrogenchloride In methanol
propionaldehyde
123-38-6

propionaldehyde

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

Conditions
ConditionsYield
In ethanol at 20℃; for 0.5h;100%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

poly[1-(4-formylphenyl)ethylene], Mn: SEC (RI)= 5500, SEC (UV)= 5000, Mw: SEC (RI)= 5900, PD: SEC (RI)= 1.07, SEC (UV)= 1.15; monomer(s): 4-vinylbenzaldehyde

poly[1-(4-formylphenyl)ethylene], Mn: SEC (RI)= 5500, SEC (UV)= 5000, Mw: SEC (RI)= 5900, PD: SEC (RI)= 1.07, SEC (UV)= 1.15; monomer(s): 4-vinylbenzaldehyde

poly{1-[4-(N-isopropyl-N-oxo-iminomethyl)phenyl]ethylene}, Mn (SEC (RI)): 16300, PD (SEC (RI)): 9.24; monomer(s): 4-vinylbenzaldehyde; N-isopropylhydroxylamine

poly{1-[4-(N-isopropyl-N-oxo-iminomethyl)phenyl]ethylene}, Mn (SEC (RI)): 16300, PD (SEC (RI)): 9.24; monomer(s): 4-vinylbenzaldehyde; N-isopropylhydroxylamine

Conditions
ConditionsYield
In chloroform at 25℃; for 24h;100%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

poly[p-vinylbenzaldehyde-co-styrene], diblock copolymer (0.85:1), Mn: SEC (RI)= 15600, SEC (UV)= 14900, PD: SEC (RI)= 1.30, SEC (UV)= 1.68, Tg: 110 deg C; monomer(s): 4-vinylbenzaldehyde; styrene

poly[p-vinylbenzaldehyde-co-styrene], diblock copolymer (0.85:1), Mn: SEC (RI)= 15600, SEC (UV)= 14900, PD: SEC (RI)= 1.30, SEC (UV)= 1.68, Tg: 110 deg C; monomer(s): 4-vinylbenzaldehyde; styrene

poly[(4-vinylbenzaldehyde-N-isopropylnitron)-co-styrene], diblock copolymer (0.85:1), Mn: SEC (RI)= 18800, SEC (UV)= 16300, PD: SEC (RI)= 1.40, SEC (UV)= 1.54; monomer(s): 4-vinylbenzaldehyde; styrene; N-isopropylhydroxylamine

poly[(4-vinylbenzaldehyde-N-isopropylnitron)-co-styrene], diblock copolymer (0.85:1), Mn: SEC (RI)= 18800, SEC (UV)= 16300, PD: SEC (RI)= 1.40, SEC (UV)= 1.54; monomer(s): 4-vinylbenzaldehyde; styrene; N-isopropylhydroxylamine

Conditions
ConditionsYield
In chloroform at 25℃; for 24h;100%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

poly[1-(3-formylphenyl)ethylene], Mn: SEC (RI)= 12600, SEC (UV)= 11800, PD: SEC (RI)= 3.42, SEC (UV)= 3.45; monomer(s): 3-vinylbenzaldehyde

poly[1-(3-formylphenyl)ethylene], Mn: SEC (RI)= 12600, SEC (UV)= 11800, PD: SEC (RI)= 3.42, SEC (UV)= 3.45; monomer(s): 3-vinylbenzaldehyde

poly{1-[3-(N-isopropyl-N-oxo-iminomethyl)phenyl]ethylene}, Mn (SEC (RI)): 13400, PD (SEC (RI)): 3.53; monomer(s): 3-vinylbenzaldehyde; N-isopropylhydroxylamine

poly{1-[3-(N-isopropyl-N-oxo-iminomethyl)phenyl]ethylene}, Mn (SEC (RI)): 13400, PD (SEC (RI)): 3.53; monomer(s): 3-vinylbenzaldehyde; N-isopropylhydroxylamine

Conditions
ConditionsYield
In chloroform at 25℃; for 24h;100%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

poly[1-(4-formyl-3-hydroxyphenyl)ethylene], Mn: SEC (RI)= 8000, SEC (UV)= 8400, Mw: SEC (RI)= 34700, SEC (UV)= 33500, PD: SEC (RI)= 4.32, SEC (UV)= 4.00; monomer(s): 2-hydroxy-4-vinylbenzaldehyde

poly[1-(4-formyl-3-hydroxyphenyl)ethylene], Mn: SEC (RI)= 8000, SEC (UV)= 8400, Mw: SEC (RI)= 34700, SEC (UV)= 33500, PD: SEC (RI)= 4.32, SEC (UV)= 4.00; monomer(s): 2-hydroxy-4-vinylbenzaldehyde

poly{1-[3-hydroxy-4-(N-isopropyl-N-oxo-iminomethyl)phenyl]ethylene}, Mn (SEC (RI)): 12800, Mw (SEC (RI)): 29600, PD (SEC (RI)): 2.30; monomer(s): 2-hydroxy-4-vinylbenzaldehyde; N-isopropylhydroxylamine

poly{1-[3-hydroxy-4-(N-isopropyl-N-oxo-iminomethyl)phenyl]ethylene}, Mn (SEC (RI)): 12800, Mw (SEC (RI)): 29600, PD (SEC (RI)): 2.30; monomer(s): 2-hydroxy-4-vinylbenzaldehyde; N-isopropylhydroxylamine

Conditions
ConditionsYield
In tetrahydrofuran at 25℃; for 24h;100%
pyridine
110-86-1

pyridine

meso-tetraphenylporphyrin iron(III) chloride
16456-81-8, 170645-84-8

meso-tetraphenylporphyrin iron(III) chloride

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

iron(II)(tetraphenylporphyrin)(pyridine)(i-Pr-NO)
84027-23-6, 64479-14-7

iron(II)(tetraphenylporphyrin)(pyridine)(i-Pr-NO)

Conditions
ConditionsYield
In chloroform 20°C, 15 h, under Ar; recrystn. from CHCl3, MeoH, pyridine; elem. anal.;100%
propionaldehyde
123-38-6

propionaldehyde

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

N-Isopropylpropylidenamin-N-oxid
107341-57-1, 118644-19-2, 118644-29-4

N-Isopropylpropylidenamin-N-oxid

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane for 15h; Ambient temperature;98%
2-hydroxy-5-formylbenzoic acid
616-76-2

2-hydroxy-5-formylbenzoic acid

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

sodium (Z)-2-hydroxy-5-((isopropyloxidoimino)methyl)benzoate

sodium (Z)-2-hydroxy-5-((isopropyloxidoimino)methyl)benzoate

Conditions
ConditionsYield
Stage #1: 2-hydroxy-5-formylbenzoic acid; N-isopropylhydroxyamine In methanol at 20℃;
Stage #2: With sodium hydroxide In methanol; water at 20℃;
96%
meso-tetraphenylporphyrin iron(III) chloride
16456-81-8, 170645-84-8

meso-tetraphenylporphyrin iron(III) chloride

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

[2-(hydroxyamino)propane](2-nitrosopropane)(meso-tetraphenylporphyrinato)iron(II)
84040-45-9

[2-(hydroxyamino)propane](2-nitrosopropane)(meso-tetraphenylporphyrinato)iron(II)

Conditions
ConditionsYield
In chloroform 6 h, under Ar; solvent was removed under vac., recrystn. from CHCl3, MeOH at -15° C; elem. anal.;95%
chlorosulfonic acid
7790-94-5

chlorosulfonic acid

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

N-isopropylhydroxylamine O-sulfonic acid
18247-17-1

N-isopropylhydroxylamine O-sulfonic acid

Conditions
ConditionsYield
In dichloromethane at -78℃; for 2h;94%
pyridine
110-86-1

pyridine

5,10,15,20-tetrakis(4-methylphenyl)porphyrinatoiron(III) chloride
19496-18-5

5,10,15,20-tetrakis(4-methylphenyl)porphyrinatoiron(III) chloride

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

(2-nitrosopropane)(pyridine)(meso-tetratolylporphyrinato)iron(II)
84027-28-1

(2-nitrosopropane)(pyridine)(meso-tetratolylporphyrinato)iron(II)

Conditions
ConditionsYield
In chloroform 20°C, 4 h, under Ar; recrystn. from CHCl3, MeOH, pyridine;93%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

3,4-dimethoxy-3-cyclobutene-1,2-dione
5222-73-1

3,4-dimethoxy-3-cyclobutene-1,2-dione

3-(N-Hydroxy-isopropylamino)-4-methoxy-3-cyclobuten-1,2-dion
100749-01-7

3-(N-Hydroxy-isopropylamino)-4-methoxy-3-cyclobuten-1,2-dion

Conditions
ConditionsYield
With potassium hydroxide In methanol at 25℃; for 1h; retro-Cope elimination reaction;92%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

5-carbomethoxythiopentanoyl 2-(5,5-dimethyl-2-thiono-1,3,2-dioxaphosphorinanyl)sulfide
473440-59-4

5-carbomethoxythiopentanoyl 2-(5,5-dimethyl-2-thiono-1,3,2-dioxaphosphorinanyl)sulfide

N-(5-carbomethoxythiopentanoyl)-N-isoprpylhydroxylamine

N-(5-carbomethoxythiopentanoyl)-N-isoprpylhydroxylamine

Conditions
ConditionsYield
With triethylamine91%
pyridine
110-86-1

pyridine

5,10,15,20-tetrakis(p-chlorophenyl)porphyrin iron(III) chloride
36965-70-5

5,10,15,20-tetrakis(p-chlorophenyl)porphyrin iron(III) chloride

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

(2-nitrosopropane)(pyridine)(meso-tetra(4-chlorophenyl)porphyrinato)iron(II)
84027-27-0

(2-nitrosopropane)(pyridine)(meso-tetra(4-chlorophenyl)porphyrinato)iron(II)

Conditions
ConditionsYield
In chloroform 20°C, 4 h, under Ar; recrystn. from CHCl3, MeOH, pyridine;90%
methanol
67-56-1

methanol

meso-tetraphenylporphyrin iron(III) chloride
16456-81-8, 170645-84-8

meso-tetraphenylporphyrin iron(III) chloride

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

(methanol)(2-nitrosopropane)(meso-tetraphenylporphyrinato)iron(II)
84027-24-7

(methanol)(2-nitrosopropane)(meso-tetraphenylporphyrinato)iron(II)

Conditions
ConditionsYield
In chloroform 20° C, 6 h, under Ar; recrystn. from CH2Cl2, MeOH; elem. anal.;90%
{bis-(p-dimethylaminophenyl)allenylidene}(pentacarbonyl)chromium

{bis-(p-dimethylaminophenyl)allenylidene}(pentacarbonyl)chromium

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

pentacarbonyl[(N-isopropyl-3,3-bis-p-dimethylaminophenyl)isoxazolidinylidene]chromium * 0.25 pentane

pentacarbonyl[(N-isopropyl-3,3-bis-p-dimethylaminophenyl)isoxazolidinylidene]chromium * 0.25 pentane

Conditions
ConditionsYield
In dichloromethane inert atmosphere; stirring Cr-complex with 1.27 equiv. of hydroxylamine derivative (room temp., 4 h); evapn. (vac.), chromy. (-20°C, SiO2, pentane/CH2Cl2/Et2O=8:1:1), evapn., crystn. (pentane/CH2Cl2=12:1); elem. anal.;90%
meso-tetraphenylporphyrin iron(III) chloride
16456-81-8, 170645-84-8

meso-tetraphenylporphyrin iron(III) chloride

isopropylamine
75-31-0

isopropylamine

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

(2-aminopropane)(2-nitrosopropane)(meso-tetraphenylporphyrinato)iron(II)
73233-48-4

(2-aminopropane)(2-nitrosopropane)(meso-tetraphenylporphyrinato)iron(II)

Conditions
ConditionsYield
In chloroform 20° C, 15 h, under Ar; recrystn. from CHCl3, MeOH, i-PrNH2 at -15° C; elem. anal.;89%
(3,4-dimethoxy-phenyl)-glyoxylonitrile
65961-86-6

(3,4-dimethoxy-phenyl)-glyoxylonitrile

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

C12H17NO4
82461-66-3

C12H17NO4

Conditions
ConditionsYield
87%
pentacarbonyl[3,3-bis(p-(dimethylamino)phenyl)-1,2-propadienylidene]tungsten

pentacarbonyl[3,3-bis(p-(dimethylamino)phenyl)-1,2-propadienylidene]tungsten

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

pentacarbonyl[(N-isopropyl-3,3-bis-p-dimethylaminophenyl)isoxazolidinylidene]tungsten * 0.25 pentane

pentacarbonyl[(N-isopropyl-3,3-bis-p-dimethylaminophenyl)isoxazolidinylidene]tungsten * 0.25 pentane

Conditions
ConditionsYield
In dichloromethane inert atmosphere; stirring W-complex with 1.3 equiv. of hydroxylamine derivative (room temp., 4 h); evapn. (vac.), chromy. (-20°C, SiO2, pentane/CH2Cl2/Et2O=7:2:1), evapn., crystn. (pentane/CH2Cl2=8:1); elem. anal.;87%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

2-phenoxybenzoic acid
2243-42-7

2-phenoxybenzoic acid

C16H17NO3

C16H17NO3

Conditions
ConditionsYield
Stage #1: 2-phenoxybenzoic acid With oxalyl dichloride In dichloromethane; N,N-dimethyl-formamide
Stage #2: N-isopropylhydroxyamine With triethylamine In tetrahydrofuran; dichloromethane; water at 23℃;
87%
pivaloyl chloride
3282-30-2

pivaloyl chloride

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

N-Isopropylpivalohydroxamsaeure
106129-12-8

N-Isopropylpivalohydroxamsaeure

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran86%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

mesitylene-2-carboxylic acid chloride
938-18-1

mesitylene-2-carboxylic acid chloride

N-isopropyl-2,4,6-trimethylbenzohydroxamic acid
1510834-18-0

N-isopropyl-2,4,6-trimethylbenzohydroxamic acid

Conditions
ConditionsYield
at 20℃; for 2h; Inert atmosphere;86%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

methyl 3-(N-hydroxy-N-isopropyl)aminopropanoate
95503-39-2

methyl 3-(N-hydroxy-N-isopropyl)aminopropanoate

Conditions
ConditionsYield
In diethyl ether Ambient temperature;84%
4-hydroxy-3,5-dimethylbenzaldehyde
2233-18-3

4-hydroxy-3,5-dimethylbenzaldehyde

N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

(Z)-N-(4-hydroxy-3, 5-dimethylbenzylidene)propan-2-amine oxide

(Z)-N-(4-hydroxy-3, 5-dimethylbenzylidene)propan-2-amine oxide

Conditions
ConditionsYield
In methanol; water at 20℃;81%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

isobutyraldehyde
78-84-2

isobutyraldehyde

(Z)-N-(2-methylpropylidene)propan-2-amine oxide
140116-61-6

(Z)-N-(2-methylpropylidene)propan-2-amine oxide

Conditions
ConditionsYield
With magnesium sulfate In chloroform for 12h; Ambient temperature;80%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

thiobutyryl 2-(5,5-dimethyl-2-thiono-1,3,2-dioxaphosphorinanyl)sulfide
463962-41-6

thiobutyryl 2-(5,5-dimethyl-2-thiono-1,3,2-dioxaphosphorinanyl)sulfide

N-isopropyl-N-thiobutyrylhydroxylamine

N-isopropyl-N-thiobutyrylhydroxylamine

Conditions
ConditionsYield
With triethylamine80%
N-isopropylhydroxyamine
5080-22-8

N-isopropylhydroxyamine

(5Z,7E,20R)-1α,3β-bis<(tert-butyldimethylsilyl)oxy>-20-formylmethyl-9,10-seco-5,7,10(19)-pregnatriene
143884-26-8

(5Z,7E,20R)-1α,3β-bis<(tert-butyldimethylsilyl)oxy>-20-formylmethyl-9,10-seco-5,7,10(19)-pregnatriene

C38H69NO3Si2
851228-80-3

C38H69NO3Si2

Conditions
ConditionsYield
Stage #1: N-isopropylhydroxyamine; (5Z,7E,20R)-1α,3β-bis<(tert-butyldimethylsilyl)oxy>-20-formylmethyl-9,10-seco-5,7,10(19)-pregnatriene With triethylamine In dichloromethane at 20℃; for 2h;
Stage #2: With ammonium chloride In dichloromethane; water
80%

5080-22-8Relevant academic research and scientific papers

N,N′-Dihydroxy-N,N′-diisopropylhexanediamide, a siderophore analogue, as a possible iron chelating agent for hydroponic conditions: metal equilibrium studies

Martins, Jo?o G.,Ferreira, Carlos M. H.,Dey, Suvendu S.,Barros, Maria Teresa,Soares, Helena M. V. M.

, p. 1079 - 1088 (2017)

Synthetic iron chelates are the most efficient iron fertilizers. The stability in solution of the iron chelates in the presence of other metal cations that may compete with iron for the chelating agent in nutrient solutions is crucial for its effectiveness in supplying iron to plants. In this work, the chelating properties of N,N-dihydroxy-N,N′-diisopropylhexanediamide (DPH), a biological model of the natural siderophore rhodotorulic acid, were evaluated in order to assess its potentialities for being used, as an iron chelate, in hydroponic cultures. For this purpose, the complexation for the metals [Ca(II), Cu(II), Mg(II), Mn(II) or Zn(II)]–DPH–OH systems has been studied using pH potentiometry and the overall stability constants have been determined for the first time. For all M–DPH–OH systems, MHL and ML species were identified. For [Cu(II), Mn(II) or Zn(II)]–DPH–OH systems, the M2L3 species was detected, whereas formation of ML(OH) species was found in the [Ca(II) or Mg(II)]–DPH–OH systems. Finally, the chemical stability of iron chelated with DPH in hydroponic conditions was assessed by computer chemical simulations and compared with the one predicted when iron is chelated with ethylenediamine-N,N′-bis(o-hydroxyphenyl)acetic acid (o,o-EDDHA) in similar conditions.

Synthesis, characterization, theoretical prediction of activities and evaluation of biological activities of some sulfacetamide based hydroxytriazenes

Agarwal, Shilpa,Baroliya, Prabhat K.,Bhargava, Amit,Tripathi,Goswami

, p. 2870 - 2873 (2016)

Six new N [(4-aminophenyl)sulfonyl]acetamide based hydroxytriazenes have been synthesized and characterized using elemental analysis, IR, 1H NMR, 13C NMR and MASS spectral analysis. Further, their theoretical predictions for probable activities have been taken using PASS (Prediction of Activity Spectra for Substance). Although a number of activities have been predicted but specifically anti-inflammatory, antiradical, anti-diabetic activities have been experimentally validated which proves that theoretical predictions agree with the experimental results. The object of the Letter is to establish Computer Aided Drug Design (CADD) using our compounds.

LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF

-

Paragraph 0154, (2021/08/20)

The present technology is directed to compounds Formulas I, II, III, and IV as well as compositions that include one or more of the compounds and methods of making the compounds. In particular, the present compounds may be used as a replacement for NMP in compositions to produce lower toxicity compositions.

Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies

Baroliya, Prabhat K.,Chauhan, R. S.,Dayma, Varsha,Dwivedi, Aparna,Goswami, A. K.,Sharma, Poonam,Tripathi, I. P.,Vanangamudi, Murugesan

, (2020/02/15)

Herein, we report synthesis, characterization, anti-diabetic, anti-inflammatory and anti-oxidant activities of hydroxytriazenes derived from sulpha drugs, namely sulphanilamide, sulphadiazine, sulphapyridine and sulphamethazine. Before biological screening of the compounds, theoretical prediction using PASS was done which indicates probable activities ranging from Pa (probable activity) values 65–98% for anti-inflammatory activity. As per the predication, experimental validation of some of the predicted activities particularly anti-diabetic, anti-inflammatory and anti-oxidant was done. Anti-diabetic activities have been screened using two methods namely α-amylase and α-glucosidase inhibition method and IC50 values were ranging from 66 to 260 and 148 to 401 μg/mL, while for standard drug acarbose the values were 12 μg/mL and 70 μg/mL, respectively. Docking studies have also been done for antidiabetic target pancreatic alpha amylase. The molecular docking studies in α-amylase enzyme reveal that the middle phenyl ring of all the compounds mainly occupies in the small hydrophobic pocket formed by the Ala198, Trp58, Leu162, Leu165 and Ile235 residues and sulphonamide moiety establish H-bond interaction by two water molecules. Further, anti-inflammatory activity has been evaluated using carrageenan induced paw-edema method and results indicate excellent anti-inflammatory activity by hydroxytriazenes (71 to 97%) and standard drug diclofenac 94% after 4 h of treatment. Moreover, antioxidant effect of the compounds was tested using DPPH and ABTS methods. All the compounds displayed good results (24–488 μg/mL) against ABTS radical and many compounds are more active than ascorbic acid (69 μg/mL) while all other compounds showed moderate activity against DPPH radical (292–774 μg/mL) and ascorbic acid (29 μg/mL). Thus, the studies reveal potential of sulfa drug based hydroxytriazenes as candidates for antidiabetic, anti-inflammatory and antioxidant activities which have been experimentally validated.

A Process for the Preparation of Isopropylhydroxylamine

-

Paragraph 0044-, (2017/01/02)

Relates to manufacturing method of the present invention refers to IPHA (Isopropylhydroxylamine), specific under the presence of a catalyst at a temperature of 50 to 200 °C 2-nitro at a pressure of 50 to 200psi with rope in petal and then hydrogenated in the hydrogenation and which may progress towards.. Said method to improve (selectivity) and selectivity obtained rate (yield) are provided to form a film with glycol by reacting relates to characterized by manufacturing method.

Method for manufacturing ammonia-N

-

Paragraph 0075-0076; 0083-0084, (2018/12/01)

PROBLEM TO BE SOLVED: To provide a method for producing an N-alkyl hydroxylamine, which produces a pure N-alkyl hydroxylamine in a high yield under a mild condition by a simple method, does not require a strict time management and is advantageous for industrial-scale production. SOLUTION: The method for producing an N-alkyl hydroxylamine includes bringing an N-alkyl nitro compound into contact with a hydrogen source in the presence of a solid catalyst supporting palladium on silica and in the absence of a significant quantity of a fourth reaction component. The method for producing an N-alkyl hydroxylamine includes bringing (A) an N-alkyl nitro compound into contact only with (B) a hydrogen source and (C) a solid catalyst supporting palladium on silica, or bringing (A) an N-alkyl nitro compound into contact only with (B) a hydrogen source, (C) a solid catalyst supporting palladium on silica and (D) a solvent that does not deactivate catalytic activity and has a pKa of ≥12. COPYRIGHT: (C)2012,JPOandINPIT

Facile reduction of nitroarenes into anilines and nitroalkanes into hydroxylamines via the rapid activation of ammonia· borane complex by supported gold nanoparticles

Vasilikogiannaki, Eleni,Gryparis, Charis,Kotzabasaki, Vasiliki,Lykakis, Ioannis N.,Stratakis, Manolis

supporting information, p. 907 - 911 (2013/05/08)

Gold nanoparticles supported on titania catalyse, even at a ppm loading level, the quantitative reduction of nitroarenes into anilines and nitroalkanes into alkylhydroxylamines by the ammonia× borane complex. No dehalohalogenation was seen in the case of chloro- or bromonitroarenes, while ester, cyano, or carboxylic acid functionalities also remain intact. The nitroarene to aniline reduction pathway does not require nitrosoarenes as intermediate products. Copyright

Highly enantioselective intermolecular hydroamination of allylic amines with chiral aldehydes as tethering catalysts

MacDonald, Melissa J.,Hesp, Colin R.,Schipper, Derek J.,Pesant, Marc,Beauchemin, André M.

supporting information, p. 2597 - 2601 (2013/03/14)

Chirally LinkedIn: Chiral aldehydes are effective tethering catalysts for enantioselective intermolecular hydroamination, which provides access to vicinal diamine motifs in good yields and excellent enantioselectivities (see scheme). This work highlights simple chiral α-oxygenated aldehydes as effective organocatalysts capable of efficiently inducing asymmetry through transient intramolecularity. Copyright

Selective synthesis of N-Alkyl hydroxylamines by hydrogenation of nitroalkanes using supported palladium catalysts

Takenaka, Yasumasa,Kiyosu, Takahiro,Choi, Jun-Chul,Sakakura, Toshiyasu,Yasuda, Hiroyuki

experimental part, p. 1166 - 1168 (2011/12/02)

The selective hydrogenation of nitroalkanes to the corresponding N-alkyl hydroxylamines is achieved at room temperature with excellent yields (up to 98 %), by using common supported palladium catalysts. The reaction temperature is key to the highly selective formation of the hydroxylamines, which proceeds smoothly in a H2 atmosphere without additives. The catalyst can be recycled up to five times.

Primary N-hydroxylamines

-

, (2008/06/13)

The invention provides pharmaceutical compositions comprising primary N-hydroxylamines and related therapeutic, prophylactic, diagnostic and screening methods. The pharmaceutical compositions generally comprise a pharmaceutical composition comprising an orally administrable effective unit solid dosage of a primary N-hydroxylamine or a pharmaceutically acceptable salt thereof and substantially free of a nitrone corresponding to the hydroxylamine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5080-22-8